Videos

Together, let's share on the future approaches for the treatment of Resistant Hypertension

Videosort ascending
Sharing together: Part II

Sharing together: Part II

Atul Pathak, Professor of Cardiology and Clinical Pharmacology, RHC 2013 Faculty member, Jean Fajadet, President of EAPCI - Felix Mahfoud, Interventional Cardiologist, Co-Chairman of RHC, and Christian Ukena, Electrophysiologist

Click here to watch

Click here to watch
Watch Sharing together: Part I

Sharing together: Part I

Jean Marco, Honorary Chairman of PCR and Felix Mahfoud, Interventional Cardiologist, Co-Chairman of RHC, Member of ESH and EAPCI

Click here to watch

Click here to watch

Roland Schmieder - On the Symplicity HTN-3 press release and hypertension treatments

Roland Schmieder (Germany) answers the following questions: - Please share with us your thoughts on the Symplicity HTN-3 press release...

Click here to watch

Click here to watch

Riaz Dawood - About resistant hypertension in South Africa

Riaz Dawood (South Africa) answers the following questions: - Please tell us about the prevalence of hypertension and especially resistant hypertension in South Africa...

Click here to watch

Click here to watch

Renal denervation – Insights and directions

RHC 2014 Symposium - Learn how the pre-clinical and clinical evidence for catheter-based renal sympathetic denervation is continuing to be built, explore anatomical considerations in patient selection, and understand the importance multidisciplinary working in establishing appropriate and sustainable patient pathways

Click here to watch

Click here to watch

Peter Blankestijn on Blood Pressure Measurement

Peter J. Blankestijn (Netherlands) answers the following questions: - Can you please explain the different modalities in measuring blood pressure, and the differences between home-based, office-based and ambulatory blood pressures?...

Click here to watch

Click here to watch

Michel Burnier on Drug Adherence and Compliance

Michel Burnier (Switzerland) answers the following questions: - Please explain the difference between drug adherence and drug compliance...

Click here to watch

Click here to watch

Michael Böhm - About the Symplicity HTN-3 press release

Michael Böhm (Germany) answers the following questions: - How does the Symplicity HTN-3 update affect your work? Do you continue renal denervation? - Further indications for renal denervation? - Can you please summarise the main points of the ReAdapt CHF trial?

Click here to watch

Click here to watch

Markus Schlaich discussing the "fil rouge" patients presented during RHC 2014

Markus Schlaich (Australia) answers the following questions: - Can you tell us more about the RHC "fil rouge" patients presented in Berlin, and the objectives of using these patients?...

Click here to watch

Click here to watch

L'hypertension artérielle aux JESFC 2014

À l'occasion des 24èmes Journées Européennes de la Société Française de Cardiologie du 15 au 18 janvier 2014, le Pr Pathak revient sur les trois informations principales discutées en conférence...

Click here to watch

Click here to watch

Pages